Integra LifeSciences (NASDAQ:IART) Price Target Raised to $28.00

Integra LifeSciences (NASDAQ:IART – Free Report) had its price objective lifted by Citigroup from $24.00 to $28.00 in a report released on Wednesday morning, Benzinga reports. They currently have a neutral rating on the life sciences company’s stock. A number of other brokerages have also recently commented on IART. StockNews.com cut Integra LifeSciences from a […]

Related Keywords

United States ,America ,Stuart Essig ,Integra Lifesciences ,Valley National Advisers Inc ,Covestor Ltd ,Integra Lifesciences Holdings Corporation ,Hexagon Capital Partners ,Citigroup ,Free Report ,Truist Financial ,Lifesciences Trading Down ,Get Free Report ,Chairman Stuart Essig ,Capital Partners ,Capital Management ,National Advisers ,Lifesciences Holdings Corporation ,Codman Specialty Surgical ,Integra Lifesciences Daily ,